Insider Cluster (2 insiders) ·Filed Apr 13, 2026

IRON

Disc Medicine, Inc.
BEARISH
Impact 7/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $261K total
Actionable Insight ▼ Bearish

Traders should monitor for potential downward pressure on the stock, especially if additional selling follows. The coordinated exit by CFO and CMO raises questions about internal confidence, particularly in a biopharma context where clinical progress is key. Absent positive news, this could signal overvaluation or upcoming risk.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IRON ▲ +16.94% at T+60d
SHORT call ✗ call lost -16.94% · α vs SPY -8.02% · entry $68.46 → $80.06
Entry anchored
Apr 10, 03:59 PM ET
via exchange tick
T+1d
+2.95%
call -2.95% · α -1.74%
$70.48
settled 6mo ago
T+5d
+4.31%
call -4.31% · α -1.01%
$71.41
settled 6mo ago
T+20d
+1.12%
call -1.12% · α +6.60%
$69.23
settled 5mo ago
T+60d
+16.94%
call -16.94% · α -8.02%
$80.06
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at Disc Medicine, Inc. (IRON) sold shares worth $694K in the past week, including CFO Jean M. Franchi and CMO William Jacob Savage. The sales were open-market transactions, representing a coordinated insider sell-off by top leadership.

Key Financial Metrics

Direction
selling
Total Value
$694.3K
Insiders
2

Key Facts

  • CFO Jean M. Franchi sold 6,657 shares for $460,834 in two transactions on April 13 and 14, 2026.
  • CMO William Jacob Savage sold 3,531 shares for $233,473 on April 13, 2026.
  • Total insider sales in the past 7 days amount to $694,307 in open-market transactions.
  • All transactions were 'S' (open-market sale) codes, indicating deliberate divestment.
  • Total value represents ~0.026% of the $2.7B market cap — modest in size but significant given concentration among C-suite executives.

Financial Impact

$694K in open-market share sales by two C-suite executives

insider ownershipinvestor sentimentperceived confidence in valuation

Risk Factors

  • Perception of insider pessimism ahead of clinical data or regulatory decisions
  • Potential for follow-on selling by other insiders
  • Increased scrutiny from retail and institutional investors

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IRON-1776287155695
20 reports for IRON
Performance horizon
75% Hit rate 6 of 8 directional calls best @ T+60▲ +17.13%Jun 9, 2026
Filters
Rows
Reports for IRON — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
8-K
BULLISH ★ 7/10
$74.14 $69.18▼ −6.69%▼ −6.19%$64.48 (−13.03%)
Sep 9, 2026
22d ago
Press Release
BULLISH ★ 7/10
$74.14 $69.18▼ −6.69%▼ −6.19%$64.48 (−13.03%)
Sep 3, 2026
28d ago
Insider Cluster
BEARISH ★ 5/10
$79.23 $68.92▲ +13.01%▲ +11.80%$64.48 (+18.62%)
Sep 2, 2026
29d ago
144
NEUTRAL ★ 2/10
$79.37 $70.06▼ −11.73%▼ −10.58%$64.48 (−18.76%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$82.55 $79.37▼ −3.85%▼ −4.12%$64.48 (−21.89%)
Aug 18, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.32 $82.67▲ +2.93%▲ +3.31%$64.48 (−19.72%)
Aug 14, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.05 $80.94▲ +1.11%▲ +2.30%$64.48 (−19.45%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 7/10
$79.21 $77.44▼ −2.23%▼ −5.86%$64.48 (−18.60%)
Jul 30, 2026
9w ago
Press Release
BULLISH ★ 7/10
$79.21 $77.44▼ −2.23%▼ −5.86%$64.48 (−18.60%)
Jul 14, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$76.02 $74.32▼ −2.24%▼ −1.26%$64.48 (−15.18%)
Showing 10 of 20

US Market Status

Market Open — Closes in 3h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 15, 2026